Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5-6
pubmed:dateCreated
2011-9-6
pubmed:abstractText
We aimed to describe the efficacy and safety of sunitinib in unselected Korean advanced renal cell carcinoma (RCC) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1423-0232
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
395-405
pubmed:meshHeading
pubmed-meshheading:21829041-Adult, pubmed-meshheading:21829041-Aged, pubmed-meshheading:21829041-Anemia, pubmed-meshheading:21829041-Antineoplastic Agents, pubmed-meshheading:21829041-Asian Continental Ancestry Group, pubmed-meshheading:21829041-Carcinoma, Renal Cell, pubmed-meshheading:21829041-Disease-Free Survival, pubmed-meshheading:21829041-Drug Administration Schedule, pubmed-meshheading:21829041-Female, pubmed-meshheading:21829041-Humans, pubmed-meshheading:21829041-Indoles, pubmed-meshheading:21829041-Kidney Neoplasms, pubmed-meshheading:21829041-Male, pubmed-meshheading:21829041-Middle Aged, pubmed-meshheading:21829041-Neutropenia, pubmed-meshheading:21829041-Nomograms, pubmed-meshheading:21829041-Predictive Value of Tests, pubmed-meshheading:21829041-Pyrroles, pubmed-meshheading:21829041-Republic of Korea, pubmed-meshheading:21829041-Risk Factors, pubmed-meshheading:21829041-Thrombocytopenia, pubmed-meshheading:21829041-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.
pubmed:affiliation
Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchondong, Seodaemun-gu, Seoul, Korea.
pubmed:publicationType
Journal Article, Clinical Trial